Merck, Eli Lilly back new Longwood Fund startup that aims to control proteins


Two Big Pharma companies are among the investors backing a new startup out of the Boston-based Longwood Fund.

Previous Gioia Capital scores first exit with sale of Home Power Systems
Next Shaq is bringing his Big Chicken franchise to Tampa Bay